Fertility Innovations is currently raising funds for the next stage of our programme of product development and clinical trials.
This offers an outstanding and exciting investment into a Company that will revolutionise the Fertility treatment market.
It represents a true Impact Investment opportunity that will benefit the world and the investor alike.
Anticipated Company Valuation in 3 to 5 years likely to be in range £100M to £500M.
We seek £8 million Series-A equity financing to achieve Marketing Approval in Europe and USA
EIS tax benefits available to qualifying investors.
Expected investor returns: 20-60x capital invested in 5 years
Fast exit possible
Exceptionally favourable risk/return ratio
You can obtain a copy of an Investment Memorandum and Application Form by contacting the company.